Table of Contents

Articles

• You have access

  D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either Receptor

  Christopher H. So, George Varghese, Kevin J. Curley, Michael M. C. Kong, Mohammed Alijaniaram, Xiaodong Ji, Tuan Nguyen, Brian F. O'Dowd and Susan R. George

  Molecular Pharmacology September 2005, 68 (3) 568-578; DOI: https://doi.org/10.1124/mol.105.012229
• You have access

  Heterozygous Deficiency of Manganese Superoxide Dismutase in Mice (Mn-SOD^+/-): A Novel Approach to Assess the Role of Oxidative Stress for the Development of Nitrate Tolerance

  Andreas Daiber, Matthias Oelze, Silke Sulyok, Meike Coldewey, Eberhard Schulz, Nicolai Treiber, Ulrich Hink, Alexander Mülsch, Karin Scharffetter-Kochanek and Thomas Münzel

  Molecular Pharmacology September 2005, 68 (3) 579-588; DOI: https://doi.org/10.1124/mol.105.011585
• You have access

  Molecular Pharmacology of Adenosine Transport in Trypanosoma brucei: P1/P2 Revisited

  Federico Geiser, Alexandra Lüscher, Harry P. de Koning, Thomas Seebeck and Pascal Mäser

  Molecular Pharmacology September 2005, 68 (3) 589-595; DOI: https://doi.org/10.1124/mol.104.010298
• You have access

  Vascular Smooth Muscle Cell Phenotype-Dependent Phosphodiesterase 4D Short Form Expression: Role of Differential Histone Acetylation on cAMP-Regulated Function

  Douglas G. Tilley and Donald H. Maurice

  Molecular Pharmacology September 2005, 68 (3) 596-605; DOI: https://doi.org/10.1124/mol.105.014126
• You have access

  Vitamin K3 (Menadione)-Induced Oncosis Associated with Keratin 8 Phosphorylation and Histone H3 Arylation

  Gary K. Scott, Christian Atsriku, Patrick Kaminker, Jason Held, Brad Gibson, Michael A. Baldwin and Christopher C. Benz

  Molecular Pharmacology September 2005, 68 (3) 606-615; DOI: https://doi.org/10.1124/mol.105.013474
• You have access

  The Reduced Folate Carrier Gene Is a Novel Selectable Marker for Recombinant Protein Overexpression

  Lilah Rothem, Bluma Berman, Michal Stark, Gerrit Jansen and Yehuda G. Assaraf

  Molecular Pharmacology September 2005, 68 (3) 616-624; DOI: https://doi.org/10.1124/mol.105.013540
• You have access

  Down-Regulation of DNA Topoisomerase IIα Leads to Prolonged Cell Cycle Transit in G₂ and Early M Phases and Increased Survival to Microtubule-Interacting Agents

  Andrzej Skladanowski, Marie-George Côme, Michal Sabisz, Alexandre E. Escargueil and Annette K. Larsen

  Molecular Pharmacology September 2005, 68 (3) 625-634; DOI: https://doi.org/10.1124/mol.105.013995
• You have access

  Apigenin Inhibits Expression of Vascular Endothelial Growth Factor and Angiogenesis in Human Lung Cancer Cells: Implication of Chemoprevention of Lung Cancer

  Ling-Zhi Liu, Jing Fang, Qiong Zhou, Xiaowen Hu, Xianglin Shi and Bing-Hua Jiang

  Molecular Pharmacology September 2005, 68 (3) 635-643; DOI: https://doi.org/10.1124/mol.105.011254
• You have access

  CYP2C9 Genotype-Dependent Effects on in Vitro Drug-Drug Interactions: Switching of Benzbromarone Effect from Inhibition to Activation in the CYP2C9.3 Variant

  Matthew A. Hummel, Charles W. Locuson, Peter M. Gannett, Dan A. Rock, Carrie M. Mosher, Allan E. Rettie and Timothy S. Tracy

  Molecular Pharmacology September 2005, 68 (3) 644-651; DOI: https://doi.org/10.1124/mol.105.013763
• You have access

  The Role of Thr139 in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Sensitivity to (+)-Calanolide A

  Joeri Auwerx, Fátima Rodríguez-Barrios, Francesca Ceccherini-Silberstein, Ana San-Félix, Sonsoles Velázquez, Erik De Clercq, María-José Camarasa, Carlo-Federico Perno, Federico Gago and Jan Balzarini

  Molecular Pharmacology September 2005, 68 (3) 652-659; DOI: https://doi.org/10.1124/mol.105.012351
• You have access

  Enhanced CCAAT/Enhancer-Binding Protein β-Liver-Enriched Inhibitory Protein Production by Oltipraz, Which Accompanies CUG Repeat-Binding Protein-1 (CUGBP1) RNA-Binding Protein Activation, Leads to Inhibition of Preadipocyte Differentiation

  Eun Ju Bae and Sang Geon Kim

  Molecular Pharmacology September 2005, 68 (3) 660-669; DOI: https://doi.org/10.1124/mol.105.012997
• You have access

  Thromboxane A₂ Promotes Interleukin-6 Biosynthesis Mediated by an Activation of Cyclic AMP-Response Element-Binding Protein in 1321N1 Human Astrocytoma Cells

  Yutaro Obara, Hitoshi Kurose and Norimichi Nakahata

  Molecular Pharmacology September 2005, 68 (3) 670-679; DOI: https://doi.org/10.1124/mol.105.012922
• You have access

  Capsaicin Regulates Voltage-Dependent Sodium Channels by Altering Lipid Bilayer Elasticity

  J. A. Lundbæk, P. Birn, S. E. Tape, G. E. S. Toombes, R. Søgaard, Roger E. Koeppe, S. M. Gruner, A. J. Hansen and O. S. Andersen

  Molecular Pharmacology September 2005, 68 (3) 680-689; DOI: https://doi.org/10.1124/mol.105.013573
• You have access

  HIV Protease Inhibitors Activate the Unfolded Protein Response in Macrophages: Implication for Atherosclerosis and Cardiovascular Disease

  Huiping Zhou, William M. Pandak, Vijay Lyall, Ramesh Natarajan and Phillip B. Hylemon

  Molecular Pharmacology September 2005, 68 (3) 690-700; DOI: https://doi.org/10.1124/mol.105.012898
• You have access

  The Role of Protein Synthesis and Degradation in the Post-Transcriptional Regulation of Rat Multidrug Resistance-Associated Protein 2 (Mrp2, Abcc2)

  B. R. Jones, W. Li, J. Cao, T. A. Hoffman, P. M. Gerk and M. Vore

  Molecular Pharmacology September 2005, 68 (3) 701-710; DOI: https://doi.org/10.1124/mol.105.013144
• You have access

  A Rapid New Assay to Detect RNA Editing Reveals Antipsychotic-Induced Changes in Serotonin-2C Transcripts

  Monsheel S. K. Sodhi, David C. Airey, Warren Lambert, Philip W. J. Burnet, Paul J. Harrison and Elaine Sanders-Bush

  Molecular Pharmacology September 2005, 68 (3) 711-719; DOI: https://doi.org/10.1124/mol.105.014134
• You have access

  Guanine Nucleotide Exchange-Independent Activation of G_s Protein by β₂-Adrenoceptor

  Özlem Uğur, Şükrü Sadik Öner, Paola Molinari, Caterina Ambrosio, Kemal Sayar and H. Ongun Onaran

  Molecular Pharmacology September 2005, 68 (3) 720-728; DOI: https://doi.org/10.1124/mol.104.010306
• You have access

  Poly(C) Binding Protein Family Is a Transcription Factor in μ-Opioid Receptor Gene Expression

  Sung-Su Kim, Krishan K. Pandey, Hack Sun Choi, Seong-Youl Kim, Ping-Yee Law, Li-Na Wei and Horace H. Loh

  Molecular Pharmacology September 2005, 68 (3) 729-736; DOI: https://doi.org/10.1124/mol.105.012245
• You have access

  Decrease in α3^*/α6^* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage

  Sarah E. McCallum, Neeraja Parameswaran, Tanuja Bordia, J. Michael McIntosh, Sharon R. Grady and Maryka Quik

  Molecular Pharmacology September 2005, 68 (3) 737-746; DOI: https://doi.org/10.1124/mol.105.012773
• You have access

  Human CYP2C8 Is Transcriptionally Regulated by the Nuclear Receptors Constitutive Androstane Receptor, Pregnane X Receptor, Glucocorticoid Receptor, and Hepatic Nuclear Factor 4α

  Stephen S. Ferguson, Yuping Chen, Edward L. LeCluyse, Masahiko Negishi and Joyce A. Goldstein

  Molecular Pharmacology September 2005, 68 (3) 747-757; DOI: https://doi.org/10.1124/mol.105.013169
• You have access

  Mechanism of Inhibition of TRPC Cation Channels by 2-Aminoethoxydiphenylborane

  Jean-Philippe Lievremont, Gary S. Bird and James W. Putney

  Molecular Pharmacology September 2005, 68 (3) 758-762; DOI: https://doi.org/10.1124/mol.105.012856
• You have access

  Identification of a Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic Acid (LY518674), That Produces Marked Changes in Serum Lipids and Apolipoprotein A-1 Expression

  Jai Pal Singh, Raymond Kauffman, William Bensch, Guoming Wang, Pam McClelland, James Bean, Chahrzad Montrose, Nathan Mantlo and Asavari Wagle

  Molecular Pharmacology September 2005, 68 (3) 763-768; DOI: https://doi.org/10.1124/mol.105.010991
• You have access

  Critical Amino Acid Residues of the Common Allosteric Site on the M₂ Muscarinic Acetylcholine Receptor: More Similarities than Differences between the Structurally Divergent Agents Gallamine and Bis(ammonio)alkane-Type Hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide

  Xi-Ping Huang, Stefanie Prilla, Klaus Mohr and John Ellis

  Molecular Pharmacology September 2005, 68 (3) 769-778; DOI: https://doi.org/10.1124/mol.105.014043
• You have access

  Pharmacological Telomerase Inhibition Can Sensitize Drug-Resistant and Drug-Sensitive Cells to Chemotherapeutic Treatment

  Ryan J. Ward and Chantal Autexier

  Molecular Pharmacology September 2005, 68 (3) 779-786; DOI: https://doi.org/10.1124/mol.105.011494
• You have access

  Novel Plant Substances Acting as β Subunit Isoform-Selective Positive Allosteric Modulators of GABA_A Receptors

  Roland Baur, Urs Simmen, Martin Senn, Urs Séquin and Erwin Sigel

  Molecular Pharmacology September 2005, 68 (3) 787-792; DOI: https://doi.org/10.1124/mol.105.011882
• You have access

  Norepinephrine Induces Lipolysis in β₁/β₂/β₃-Adrenoceptor Knockout Mice

  Geneviève Tavernier, Maria Jimenez, Jean-Paul Giacobino, Nicolas Hulo, Max Lafontan, Patrick Muzzin and Dominique Langin

  Molecular Pharmacology September 2005, 68 (3) 793-799; DOI: https://doi.org/10.1124/mol.105.014670
• You have access

  Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin

  Masaru Hirano, Kazuya Maeda, Soichiro Matsushima, Yoshitane Nozaki, Hiroyuki Kusuhara and Yuichi Sugiyama

  Molecular Pharmacology September 2005, 68 (3) 800-807; DOI: https://doi.org/10.1124/mol.105.014019
• You have access

  CYP3A5 mRNA Degradation by Nonsense-Mediated mRNA Decay

  Florent Busi and Thierry Cresteil

  Molecular Pharmacology September 2005, 68 (3) 808-815; DOI: https://doi.org/10.1124/mol.105.014225
• You have access

  Increased Bcl2 Expression by Antisense Oligoribonucleotides Targeting the Adenine-Uridine-Rich Element Motif

  Laura Ghisolfi, Laura Papucci, Annamaria Bevilacqua, Gianfranco Canti, Giuseppe Tataranni, Andrea Lapucci, Nicola Schiavone, Sergio Capaccioli and Angelo Nicolin

  Molecular Pharmacology September 2005, 68 (3) 816-821; DOI: https://doi.org/10.1124/mol.105.014357
• You have access

  Effects of Quinine, Quinidine, and Chloroquine on α9α10 Nicotinic Cholinergic Receptors

  Jimena A. Ballestero, Paola V. Plazas, Sebastian Kracun, María E. Gómez-Casati, Julián Taranda, Carla V. Rothlin, Eleonora Katz, Neil S. Millar and A. Belén Elgoyhen

  Molecular Pharmacology September 2005, 68 (3) 822-829; DOI: https://doi.org/10.1124/mol.105.014431
• You have access

  Uridine Binding and Transportability Determinants of Human Concentrative Nucleoside Transporters

  Jing Zhang, Kyla M. Smith, Tracey Tackaberry, Frank Visser, Morris J. Robins, Lars P. C. Nielsen, Ireneusz Nowak, Edward Karpinski, Stephen A. Baldwin, James D. Young and Carol E. Cass

  Molecular Pharmacology September 2005, 68 (3) 830-839; DOI: https://doi.org/10.1124/mol.105.012187
• You have access

  The Gln⁴⁸⁶³Ala Mutation within a Putative, Pore-Lining Trans-Membrane Helix of the Cardiac Ryanodine Receptor Channel Alters Both the Kinetics of Ryanoid Interaction and the Subsequent Fractional Conductance

  Kishani M. Ranatunga, Tracy M. Moreno-King, Bhavna Tanna, Ruiwu Wang, S. R. Wayne Chen, Luc Ruest, William Welch and Alan J. Williams

  Molecular Pharmacology September 2005, 68 (3) 840-846; DOI: https://doi.org/10.1124/mol.105.012807
• You have access

  Redox Regulation of PTEN by S-Nitrosothiols

  Chang-Xi Yu, Sheng Li and A. Richard Whorton

  Molecular Pharmacology September 2005, 68 (3) 847-854; DOI: https://doi.org/10.1124/mol.104.010504
• You have access

  Intracellular K⁺ Is Required for the Inactivation-Induced High-Affinity Binding of Cisapride to HERG Channels

  Jijin Lin, Jun Guo, Hongying Gang, Peter Wojciechowski, Jeffrey T. Wigle and Shetuan Zhang

  Molecular Pharmacology September 2005, 68 (3) 855-865; DOI: https://doi.org/10.1124/mol.105.012278
• You have access

  Identification of Four Novel Exon 5 Splice Variants of the Mouse μ-Opioid Receptor Gene: Functional Consequences of C-Terminal Splicing

  Ying-Xian Pan, Jin Xu, Elizabeth Bolan, Howard S. Moskowitz, Mingming Xu and Gavril W. Pasternak

  Molecular Pharmacology September 2005, 68 (3) 866-875; DOI: https://doi.org/10.1124/mol.105.011858
• You have access

  Novel Potent Human Ether-à-Go-Go-Related Gene (hERG) Potassium Channel Enhancers and Their in Vitro Antiarrhythmic Activity

  Jun Zhou, Corinne E. Augelli-Szafran, Jenifer A. Bradley, Xian Chen, Bryan J. Koci, Walter A. Volberg, Zhuoqian Sun and Jason S. Cordes

  Molecular Pharmacology September 2005, 68 (3) 876-884; DOI: https://doi.org/10.1124/mol.105.014035
• You have access

  Monitoring the Activation State of the Insulin-Like Growth Factor-1 Receptor and Its Interaction with Protein Tyrosine Phosphatase 1B Using Bioluminescence Resonance Energy Transfer

  Christophe Blanquart, Nicolas Boute, Danièle Lacasa and Tarik Issad

  Molecular Pharmacology September 2005, 68 (3) 885-894; DOI: https://doi.org/10.1124/mol.105.013151
• You have access

  Gallotannin Inhibits the Expression of Chemokines and Inflammatory Cytokines in A549 Cells

  Katalin Erdèlyi, Andrea Kiss, Edina Bakondi, Péter Bai, Csaba Szabó, Pál Gergely, Ferenc Erdödi and László Virág

  Molecular Pharmacology September 2005, 68 (3) 895-904; DOI: https://doi.org/10.1124/mol.105.012518
• You have access

  Functional Complementation and the Analysis of Opioid Receptor Homodimerization

  Geraldine Pascal and Graeme Milligan

  Molecular Pharmacology September 2005, 68 (3) 905-915; DOI: https://doi.org/10.1124/mol.105.013847